About CancerVax
CancerVax is a company based in Carlsbad (United States) founded in 1998. CancerVax has raised $58 million across 3 funding rounds from investors including J P Morgan, GE Capital and China Developement Bank. CancerVax operates in a competitive market with competitors including Helsinn, Aster Insights, Abogen Biosciences, OnCusp and Oncotherapeutics, among others.
- Headquarter Carlsbad, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$58 M (USD)
in 3 rounds
-
Latest Funding Round
$1 M (USD), Unspecified
Oct 13, 2023
-
Investors
J P Morgan
& 11 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of CancerVax
CancerVax has successfully raised a total of $58M across 3 strategic funding rounds. The most recent funding activity was a Unspecified round of $1 million completed in October 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in CancerVax
CancerVax has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include J P Morgan, GE Capital and China Developement Bank.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
US focused early stage venture capital firm
|
Locked | Locked | Locked | |
|
Venture capital fund focused on early-stage healthcare startups
|
Locked | Locked | Locked | |
|
Life Sciences & Offline focused early stage VC firm investing in the US
|
Locked | Locked | Locked |
Investor details for CancerVax
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CancerVax
Investment portfolio details for CancerVax
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - CancerVax
Detailed financials for CancerVax
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cancervax Comparisons
Peer comparison for CancerVax
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CancerVax
CancerVax operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Helsinn, Aster Insights, Abogen Biosciences, OnCusp and Oncotherapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Oncology therapeutics are developed, manufactured, and commercialized by Helsinn.
|
|
| Locked | Locked | Locked |
Contract-based oncology clinical trial services are provided by Aster Insights.
|
|
| Locked | Locked | Locked |
mRNA-based therapeutics are developed for cancer and infectious diseases.
|
|
| Locked | Locked | Locked |
CRO offering clinical development services for oncology drugs
|
|
| Locked | Locked | Locked |
Preclinical and clinical oncology drug development services are provided.
|
Detailed competitors of CancerVax
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cancervax
Complete news archive for CancerVax
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CancerVax
CancerVax was founded in 1998 and raised its 1st funding round 4 years after it was founded.
CancerVax is headquartered in Carlsbad, United States. It is registered at Carlsbad, California, United States.
David Hale is the current CEO of CancerVax.
CancerVax is a funded company, having raised a total of $58M across 3 funding rounds to date.
CancerVax was established in 1998 and is based in Carlsbad, United States. Operations are centered in the biotechnology sector, specifically oncology and immunotherapy. Focus is placed on developing vaccines targeted at cancer treatment. Research activities are led from the companys headquarters, with David Hale serving as CEO. Limited public details are available regarding specific products or partnerships.
CancerVax has 12 investors. Key investors include J P Morgan, GE Capital, China Developement Bank, Athenian Venture Partners, and SV Health Investors.